For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Migenix, Inc.

Calculating rank

USPTO Granted Patents = 20

% Expired Patents = 75.0

EPO Patents = 1

Forward Citations = 66

Loading Chart...

Loading Chart...

34 inventors (with patents filed for the assignee):

Soumitra S Ghosh (8 out of 59 patents)

Robert E Davis (7 out of 145 patents)

Yazhong Pei (6 out of 29 patents)

4. Christen M Anderson (6 out of 13 patents)

5. Tomas R Szabo (6 out of 8 patents)

6. William Christensen Clevenger (5 out of 10 patents)

7. Sandra Eileen Wiley (5 out of 7 patents)

8. Walter H Moos (4 out of 40 patents)

9. Radhakrishnan P Iyer (3 out of 38 patents)

10. Yi Jin (3 out of 24 patents)

11. Arlene Roland (3 out of 4 patents)

12. Wenqiang Zhou (3 out of 4 patents)

13. Scott W Miller (3 out of 6 patents)

14. Dale R Cameron (2 out of 27 patents)

15. Janet R Fraser (2 out of 7 patents)

20 patents: Sort by Forward Citations

1. 7709449 - Nucleic acid-based compounds and methods of use thereof (2010-05-04),

2. 7655623 - [object Object] (2010-02-02),

3. 7390787 - Compositions and methods for treating infections using analogues of indolicidin (2008-06-24),

4. 7309759 - Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics (2007-12-18),

5. 7304171 - Compounds and methods for cytoprotection (2007-12-04),

6. 7256179 - Nucleic acid-based compounds and methods of use thereof (2007-08-14),

7. 7230132 - Aryl N-cyanoguanidines and methods related thereto (2007-06-12),

8. 7138487 - Extractive purification of lipopeptide antibiotics (2006-11-21),

9. 7125844 - [object Object] (2006-10-24),

10. 7005274 - Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass (2006-02-28),

11. 7001729 - Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor (2006-02-21),

12. 6946261 - Efficient methods for producing anti-microbial cationic peptides in host cells (2005-09-20),

13. 6936638 - Ligands of adenine nucleotide translocase (ANT) and compositions and methods related thereto (2005-08-30),

14. 6927218 - Aryl N-cyanoguanidines and methods related thereto (2005-08-09),

15. 6906175 - Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor. (2005-06-14),

Company Overview

Migenix, Inc. is a biotechnology company based in San Diego, California, specializing in the development of innovative therapeutics for the treatment of infectious diseases and cancer. The company focuses on leveraging advanced research in drug development to address unmet medical needs. Migenix aims to enhance patient outcomes through its proprietary technologies and is committed to advancing healthcare solutions that improve the quality of life for patients globally.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

20 Patents

#303 in San Diego, CA

#3,940 in California

#16,409 in US

#31,295 in the World

San Diego, CA, United States of America

Migenix, Inc.

Forward Citations = 66

34 inventors:

Soumitra S Ghosh (8 out of 59 patents)

Robert E Davis (7 out of 145 patents)

Yazhong Pei (6 out of 29 patents)

4. Christen M Anderson (6 out of 13 patents)

5. Tomas R Szabo (6 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Migenix, Inc.. Retrieved from https://idiyas.com/company/migenix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…